Top 100 Contractors in PSC 6505: Drugs and Biologicals, Aug 2025–Jul 2026

Parent companies by net contract obligations Aug 1, 2025 – Jul 31, 2026 Code page on GovTribe

The latest 12 months. See the newest fiscal year's list: Top Contractors in PSC 6505: Drugs and Biologicals, FY2025.

The top 10 won 95% of PSC 6505 contract dollars from August 2025 through July 2026

Ranking facts

Contract obligations
$21,475,378,325 Net of deobligations, by contracts coded PSC 6505
Contractors
372 Parent companies with an obligation
Largest contractor
Mckesson Corporation $12 billion, 55.1% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV · Free to reuse with credit to GovTribe (CC BY 4.0)

Full ranking

Rank Contractor Net obligations Share Trend
1 $11,963,772,064
Rank history: #2 in FY2021, #2 in FY2022, #1 in FY2023, #1 in FY2024 and #1 in FY2025; unchanged since Aug 2024–Jul 2025.
2 $7,809,272,016
Rank history: #5 in FY2021, #6 in FY2022, #3 in FY2023, #2 in FY2024 and #2 in FY2025; unchanged since Aug 2024–Jul 2025.
3 $267,267,058
Rank history: #10 in FY2021, #10 in FY2022, #5 in FY2023, #5 in FY2024 and #3 in FY2025; up 2 since Aug 2024–Jul 2025.
4 $223,798,176
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
5 $139,788,297
Rank history: not on the FY2021–FY2023 lists, #25 in FY2024 and #6 in FY2025; up 2 since Aug 2024–Jul 2025.
6 $104,980,296
Rank history: not on the FY2021–FY2024 lists and #10 in FY2025; up 3 since Aug 2024–Jul 2025.
7
Meridian Medical Technologies, LLC 2 awardees
$70,298,008
Rank history: not on the FY2021–FY2023 lists, #60 in FY2024 and #84 in FY2025; up 42 since Aug 2024–Jul 2025.
8 $65,536,123
Rank history: #20 in FY2021, #18 in FY2022, #9 in FY2023, #9 in FY2024 and #8 in FY2025; unchanged since Aug 2024–Jul 2025.
9 $55,273,060
Rank history: not on the FY2021–FY2023 lists, #10 in FY2024 and #11 in FY2025; new, not ranked in Aug 2024–Jul 2025.
10 $42,318,700
Rank history: not on the FY2021–FY2023 lists, #23 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
11 $42,247,141
Rank history: not on the FY2021–FY2023 lists, #14 in FY2024 and #14 in FY2025; up 2 since Aug 2024–Jul 2025.
12 $37,485,000
Rank history: not on the FY2021–FY2024 lists and #15 in FY2025; new, not ranked in Aug 2024–Jul 2025.
13 $36,719,769
Rank history: not on the FY2021 list, #38 in FY2022, #17 in FY2023, #19 in FY2024 and #16 in FY2025; up 7 since Aug 2024–Jul 2025.
14 $36,658,160
Rank history: not on the FY2021–FY2024 lists and #9 in FY2025; down 4 since Aug 2024–Jul 2025.
15 $35,807,639
Rank history: not on the FY2021 list, #14 in FY2022, #16 in FY2023, not on the FY2024 list and #12 in FY2025; down 4 since Aug 2024–Jul 2025.
16 $34,050,073
Rank history: not on the FY2021 list, #11 in FY2022, #99 in FY2023, not on the FY2024 list and #7 in FY2025; down 4 since Aug 2024–Jul 2025.
17 $33,392,936
Rank history: #29 in FY2021, not on the FY2022–FY2024 lists and #19 in FY2025; new, not ranked in Aug 2024–Jul 2025.
18 $33,237,040
Rank history: not on the FY2021–FY2023 lists, #15 in FY2024 and not on the FY2025 list; down 2 since Aug 2024–Jul 2025.
19
Novartis Pharmaceuticals Corporation 2 awardees
$30,007,647
Rank history: not on the FY2021–FY2024 lists and #20 in FY2025; up 4 since Aug 2024–Jul 2025.
20 $29,998,678
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
21 $29,525,406
Rank history: #31 in FY2021, #27 in FY2022, #13 in FY2023, #17 in FY2024 and #17 in FY2025; down 6 since Aug 2024–Jul 2025.
22 $21,779,504
Rank history: not on the FY2021–FY2023 lists, #27 in FY2024 and #21 in FY2025; down 8 since Aug 2024–Jul 2025.
23 $21,578,657
Rank history: #21 in FY2021, #23 in FY2022, #10 in FY2023, #20 in FY2024 and #28 in FY2025; up 13 since Aug 2024–Jul 2025.
24 $17,471,250
Rank history: #26 in FY2021, not on the FY2022 list, #11 in FY2023, #26 in FY2024 and #45 in FY2025; up 20 since Aug 2024–Jul 2025.
25 $16,795,109
Rank history: not on the FY2021–FY2024 lists and #23 in FY2025; up 177 since Aug 2024–Jul 2025.
26 $16,599,962
Rank history: not on the FY2021–FY2023 lists, #18 in FY2024 and #27 in FY2025; down 7 since Aug 2024–Jul 2025.
27 $15,568,890
Rank history: not on the FY2021–FY2022 lists, #33 in FY2023, not on the FY2024 list and #26 in FY2025; up 94 since Aug 2024–Jul 2025.
28 $10,938,098
Rank history: #41 in FY2021, #33 in FY2022, #20 in FY2023, #28 in FY2024 and #22 in FY2025; down 2 since Aug 2024–Jul 2025.
29 $9,693,087
Rank history: not on the FY2021–FY2024 lists and #41 in FY2025; up 73 since Aug 2024–Jul 2025.
30
Fresenius Medical Care Holdings Inc. 2 awardees, including Fresenius Kabi, LLC and Fenwal, Inc.
$9,446,508
Rank history: not on the FY2021–FY2025 lists; up 154 since Aug 2024–Jul 2025.
31 $9,414,430
Rank history: not on the FY2021–FY2023 lists, #61 in FY2024 and #29 in FY2025; down 3 since Aug 2024–Jul 2025.
32 $9,004,206
Rank history: #25 in FY2021, not on the FY2022–FY2023 lists, #21 in FY2024 and #36 in FY2025; down 11 since Aug 2024–Jul 2025.
33 $8,099,930
Rank history: not on the FY2021 list, #58 in FY2022, not on the FY2023–FY2024 lists and #32 in FY2025; new, not ranked in Aug 2024–Jul 2025.
34 $8,070,451
Rank history: #8 in FY2021, #5 in FY2022, #45 in FY2023, #11 in FY2024 and #18 in FY2025; down 16 since Aug 2024–Jul 2025.
35 $7,615,500
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
36 $6,940,251
Rank history: not on the FY2021–FY2023 lists, #55 in FY2024 and #38 in FY2025; down 1 since Aug 2024–Jul 2025.
37 $6,930,649
Rank history: not on the FY2021–FY2023 lists, #31 in FY2024 and #24 in FY2025; down 13 since Aug 2024–Jul 2025.
38 $6,881,184
Rank history: not on the FY2021 list, #50 in FY2022, not on the FY2023 list, #44 in FY2024 and not on the FY2025 list; up 4 since Aug 2024–Jul 2025.
39 $6,856,159
Rank history: not on the FY2021–FY2023 lists, #43 in FY2024 and #33 in FY2025; down 5 since Aug 2024–Jul 2025.
40 $6,086,126
Rank history: not on the FY2021–FY2024 lists and #43 in FY2025; up 83 since Aug 2024–Jul 2025.
41 $5,766,992
Rank history: #86 in FY2021, #65 in FY2022, #44 in FY2023, #83 in FY2024 and #59 in FY2025; up 25 since Aug 2024–Jul 2025.
42 $5,212,573
Rank history: not on the FY2021–FY2024 lists and #75 in FY2025; up 36 since Aug 2024–Jul 2025.
43 $5,152,234
Rank history: not on the FY2021–FY2024 lists and #53 in FY2025; up 18 since Aug 2024–Jul 2025.
44 $4,974,870
Rank history: not on the FY2021–FY2024 lists and #44 in FY2025; new, not ranked in Aug 2024–Jul 2025.
45
Boehringer Ingelheim Animal Health USA Inc
$4,464,432
Rank history: not on the FY2021–FY2022 lists, #36 in FY2023, #37 in FY2024 and #37 in FY2025; down 14 since Aug 2024–Jul 2025.
46 $4,379,828
Rank history: #58 in FY2021, #55 in FY2022, #40 in FY2023, #47 in FY2024 and #39 in FY2025; down 6 since Aug 2024–Jul 2025.
47 $4,328,363
Rank history: not on the FY2021 list, #72 in FY2022, #48 in FY2023, #99 in FY2024 and #54 in FY2025; new, not ranked in Aug 2024–Jul 2025.
48
North American Rescue, LLC
$4,276,521
Rank history: not on the FY2021–FY2023 lists, #74 in FY2024 and #52 in FY2025; up 5 since Aug 2024–Jul 2025.
49 $4,270,545
Rank history: #57 in FY2021, #60 in FY2022, #50 in FY2023, #52 in FY2024 and #48 in FY2025; down 1 since Aug 2024–Jul 2025.
50 $4,250,023
Rank history: #71 in FY2021, #85 in FY2022, #39 in FY2023, #46 in FY2024 and #42 in FY2025; down 7 since Aug 2024–Jul 2025.
51 $3,790,248
Rank history: #76 in FY2021, #64 in FY2022, #46 in FY2023, #54 in FY2024 and #51 in FY2025; up 9 since Aug 2024–Jul 2025.
52 $3,696,281
Rank history: #42 in FY2021, #47 in FY2022, #26 in FY2023, #41 in FY2024 and #47 in FY2025; down 6 since Aug 2024–Jul 2025.
53 $3,182,122
Rank history: not on the FY2021–FY2024 lists and #66 in FY2025; up 22 since Aug 2024–Jul 2025.
54 $3,136,368
Rank history: not on the FY2021–FY2024 lists and #61 in FY2025; up 8 since Aug 2024–Jul 2025.
55 $3,047,906
Rank history: #46 in FY2021, #39 in FY2022, not on the FY2023 list, #62 in FY2024 and #68 in FY2025; up 14 since Aug 2024–Jul 2025.
56 $2,927,487
Rank history: not on the FY2021–FY2023 lists, #7 in FY2024 and #49 in FY2025; down 50 since Aug 2024–Jul 2025.
57 $2,682,099
Rank history: #37 in FY2021, #51 in FY2022, #47 in FY2023, #53 in FY2024 and #73 in FY2025; up 16 since Aug 2024–Jul 2025.
58 $2,651,492
Rank history: not on the FY2021–FY2022 lists, #90 in FY2023, #56 in FY2024 and #57 in FY2025; down 2 since Aug 2024–Jul 2025.
59 $2,551,376
Rank history: not on the FY2021 list, #78 in FY2022, #73 in FY2023, #88 in FY2024 and #78 in FY2025; up 21 since Aug 2024–Jul 2025.
60 $2,159,708
Rank history: not on the FY2021 list, #97 in FY2022, not on the FY2023–FY2024 lists and #82 in FY2025; up 7 since Aug 2024–Jul 2025.
61 $1,990,001
Rank history: not on the FY2021–FY2025 lists; up 15 since Aug 2024–Jul 2025.
62 $1,868,167
Rank history: not on the FY2021 list, #61 in FY2022, not on the FY2023 list, #76 in FY2024 and #67 in FY2025; up 6 since Aug 2024–Jul 2025.
63 $1,845,801
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
64
American Regent Inc
$1,804,958
Rank history: not on the FY2021–FY2024 lists and #70 in FY2025; up 58 since Aug 2024–Jul 2025.
65 $1,800,000
Rank history: not on the FY2021–FY2025 lists; up 195 since Aug 2024–Jul 2025.
66 $1,733,233
Rank history: #1 in FY2021, #1 in FY2022, #4 in FY2023, not on the FY2024 list and #63 in FY2025; new, not ranked in Aug 2024–Jul 2025.
67 $1,578,602
Rank history: not on the FY2021–FY2024 lists and #87 in FY2025; up 22 since Aug 2024–Jul 2025.
68 $1,567,292
Rank history: #97 in FY2021, #90 in FY2022, #77 in FY2023, #67 in FY2024 and not on the FY2025 list; up 17 since Aug 2024–Jul 2025.
69
Priority Healthcare Distribution Inc. 2 awardees
$1,521,999
Rank history: not on the FY2021–FY2023 lists, #72 in FY2024 and #64 in FY2025; down 4 since Aug 2024–Jul 2025.
70 $1,498,826
Rank history: not on the FY2021 list, #91 in FY2022, not on the FY2023 list, #86 in FY2024 and not on the FY2025 list; up 42 since Aug 2024–Jul 2025.
71 $1,483,942
Rank history: not on the FY2021–FY2024 lists and #74 in FY2025; up 1 since Aug 2024–Jul 2025.
72 $1,421,404
Rank history: #66 in FY2021, #81 in FY2022, #59 in FY2023, #75 in FY2024 and #86 in FY2025; up 14 since Aug 2024–Jul 2025.
73 $1,381,695
Rank history: #48 in FY2021, #52 in FY2022, #51 in FY2023, #81 in FY2024 and #83 in FY2025; up 9 since Aug 2024–Jul 2025.
74 $1,280,159
Rank history: not on the FY2021–FY2025 lists; up 94 since Aug 2024–Jul 2025.
75 $1,241,915
Rank history: #98 in FY2021, #93 in FY2022, #63 in FY2023, #70 in FY2024 and not on the FY2025 list; up 65 since Aug 2024–Jul 2025.
76 $1,231,578
Rank history: #49 in FY2021, #77 in FY2022, #57 in FY2023, not on the FY2024 list and #71 in FY2025; up 14 since Aug 2024–Jul 2025.
77 $1,186,384
Rank history: #27 in FY2021, #31 in FY2022, #69 in FY2023, not on the FY2024 list and #69 in FY2025; new, not ranked in Aug 2024–Jul 2025.
78 $1,162,923
Rank history: #88 in FY2021, #84 in FY2022, #72 in FY2023, not on the FY2024 list and #76 in FY2025; up 1 since Aug 2024–Jul 2025.
79 $1,134,693
Rank history: #72 in FY2021, #70 in FY2022, #61 in FY2023, #84 in FY2024 and #72 in FY2025; down 9 since Aug 2024–Jul 2025.
80 $1,105,863
Rank history: not on the FY2021–FY2025 lists; up 105 since Aug 2024–Jul 2025.
81 $1,049,478
Rank history: #96 in FY2021, not on the FY2022–FY2023 lists, #94 in FY2024 and #92 in FY2025; up 16 since Aug 2024–Jul 2025.
82 $1,007,716
Rank history: not on the FY2021–FY2024 lists and #35 in FY2025; down 43 since Aug 2024–Jul 2025.
83 $1,000,410
Rank history: not on the FY2021–FY2024 lists and #97 in FY2025; up 18 since Aug 2024–Jul 2025.
84 $960,192
Rank history: not on the FY2021–FY2024 lists and #95 in FY2025; up 15 since Aug 2024–Jul 2025.
85 $958,570
Rank history: not on the FY2021–FY2025 lists; up 355 since Aug 2024–Jul 2025.
86 $898,721
Rank history: not on the FY2021–FY2022 lists, #76 in FY2023, not on the FY2024 list and #80 in FY2025; down 3 since Aug 2024–Jul 2025.
87 $866,117
Rank history: not on the FY2021–FY2024 lists and #96 in FY2025; up 27 since Aug 2024–Jul 2025.
88
Medtronic Inc. 3 awardees, including INO Therapeutics LLC and Therakos LLC
$857,722
Rank history: not on the FY2021–FY2023 lists, #87 in FY2024 and #89 in FY2025; up 8 since Aug 2024–Jul 2025.
89
Merz Pharmaceuticals LLC
$853,397
Rank history: not on the FY2021–FY2025 lists; up 31 since Aug 2024–Jul 2025.
90 $825,142
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
91 $803,905
Rank history: not on the FY2021–FY2024 lists and #34 in FY2025; down 54 since Aug 2024–Jul 2025.
92
Astrazeneca Pharmaceuticals LP 2 awardees, including Alexion Pharmaceuticals Inc.
$733,852
Rank history: not on the FY2021–FY2023 lists, #85 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
93 $718,173
Rank history: not on the FY2021–FY2025 lists; up 154 since Aug 2024–Jul 2025.
94 $709,217
Rank history: not on the FY2021–FY2023 lists, #79 in FY2024 and #98 in FY2025; up 13 since Aug 2024–Jul 2025.
95 $691,620
Rank history: not on the FY2021–FY2025 lists; up 79 since Aug 2024–Jul 2025.
96 $677,224
Rank history: not on the FY2021–FY2025 lists; up 56 since Aug 2024–Jul 2025.
97
Zoll Medical Corporation 2 awardees, including Zoll Data Systems, Inc.
$654,679
Rank history: not on the FY2021–FY2023 lists, #38 in FY2024 and not on the FY2025 list; down 59 since Aug 2024–Jul 2025.
98 $617,531
Rank history: not on the FY2021–FY2025 lists; up 53 since Aug 2024–Jul 2025.
99 $616,000
Rank history: not on the FY2021–FY2023 lists, #33 in FY2024 and #40 in FY2025; down 70 since Aug 2024–Jul 2025.
100 $566,272
Rank history: not on the FY2021 list, #98 in FY2022, #92 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
Show 75 more

100 of 372 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $21.7 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. An awardee whose own actions mostly name no parent, and that no other company's actions name as their parent, rolls up its SAM.gov registration's chain of parent companies: it counts under the first company there that other companies' actions name as their parent, or under the parent most of a company's own actions name, whichever comes first; with neither, under the highest company in the chain with federal contracts of its own. Joint ventures stay companies of their own. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Period: the trailing 12 months end with the last month that ended at least 90 days ago, because the Department of Defense reports its contract actions to FPDS about 90 days late. The list is rebuilt each night.
  • Rank changes compare with Aug 2024–Jul 2025. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 6505 contractors in Aug 2025–Jul 2026?

1. Mckesson Corporation ($12B), 2. Cencora, Inc. ($7.81B), 3. DMS Pharmaceutical Group Inc. ($267M), 4. Albert B. Sabin Vaccine Institute, Inc. (The) ($224M), 5. Emergent Biosolutions Inc. ($140M), 6. Exelan Pharmaceuticals Inc. ($105M), 7. Meridian Medical Technologies, LLC ($70.3M), 8. Government of the United States ($65.5M), 9. Nighthawk Biosciences, Inc. ($55.3M), 10. Roche Holdings Inc. ($42.3M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work